CHEMCATCHEM
FULL PAPERS
3.80 (m, 4H), 2.55–2.16 (m, 3H), 2.06 (d, J=1.4 Hz, 6H), 1.43 (d, J=
14.3 Hz, 1H), 1.29 ppm (s, 3H); CSP-HPLC (ID, n-hexane/iPrOH
(64.3 mg, 0.20 mmol) at 208C for 9 days. Colorless solid (54 mg,
84% yield); H NMR (300 MHz, CDCl3): d=9.22 (s, 1H), 7.72 (d, J=
1
80:20, 1 mLminꢀ1
,
215 nm): er=79:21; tR(major)=8.74 min, tR-
8.3 Hz, 2H), 7.35 (d, J=8.0 Hz, 2H), 5.22 (s, 1H), 5.03 (t, J=1.8 Hz,
1H), 3.95–3.67 (m, 3H), 3.09 (d, J=10.0 Hz, 1H), 2.44 (s, 3H), 1.88–
1.69 (m, 1H), 1.59–1.43 (m, 1H), 1.37–1.16 (m, 2H), 1.16–0.99 (m,
2H), 0.85 ppm (t, J=7.2 Hz, 3H); CSP-HPLC (IC, n-hexane/iPrOH
50:50, 1 mLminꢀ1, 215 nm): er=72.5:27.5; tR(minor)=36.16 min, tR-
(major)=30.84 min; ½aꢁ2D0 = +39.8 (c=1 in CHCl3).
(minor)=11.11 min; ½aꢁ2D0 =ꢀ44.7 (c=0.42 in CHCl3).
3-Methyl-4-methylenespiro[cyclopentane-1,9’-fluorene]-3-carbalde-
hyde (2h): Prepared according to the above general protocol start-
ing from 1h (55.0 mg, 0.20 mmol) at 208C for 14 days. Yellow oil
(38 mg, 69% yield); 1H NMR (300 MHz, CDCl3): d=9.56 (s, 1H),
7.77–7.66 (m, 2H), 7.66–7.58 (m, 1H), 7.52–7.44 (m, 1H), 7.41–7.27
(m, 4H), 5.30 (dd, J=2.3, 1.1 Hz, 1H), 5.20 (dd, J=2.3, 1.0 Hz, 1H),
3.17 (d, J=14.4 Hz, 1H), 2.93 (dt, J=15.3, 2.3 Hz, 1H), 2.67–2.54 (m,
1H), 1.98 (d, J=14.4 Hz, 1H), 1.56 ppm (s, 3H); 13C NMR (75 MHz,
CDCl3): d=199.9, 153.7, 152.7, 151.6, 139.8, 139.4, 127.9, 127.6,
127.4, 127.3, 123.5, 123.0, 119.9, 119.7, 110.2, 58.1, 54.2, 46.4, 44.8,
3-Benzyl-4-methylene-1-tosylpyrrolidine-3-carbaldehyde
(6c):[8d]
Prepared according to the above general protocol starting from 5c
(71.0 mg, 0.20 mmol) at 208C for 13 days. Colorless solid (50 mg,
1
80% yield); H NMR (300 MHz, CDCl3): d=9.30 (s, 1H), 7.57 (d, J=
8.3 Hz, 2H), 7.34–7.04 (m, 5H), 7.01–6.87 (m, 2H), 5.21 (s, 1H), 5.04
(s, 1H), 3.79–3.57 (m, 2H), 3.46 (d, J=10.2 Hz, 1H), 3.17 (d, J=
10.2 Hz, 1H), 3.15 (d, J=14.0 Hz, 1H), 2.76 (d, J=14.0 Hz, 1H),
21.2 ppm; CSP-HPLC (OD-H, n-hexane/iPrOH 90:10, 1 mLminꢀ1
,
2.36 ppm (s, 3H); CSP-HPLC (IA, n-hexane/iPrOH 70:30, 1 mLminꢀ1
,
215 nm): er=72.5:27.5; tR(minor)=9.30 min, tR(major)=11.93 min;
½aꢁ2D0 = +122.28 (c=1.0 in CHCl3).
215 nm): er=69.5:30.5; tR(minor)=7.76 i, tR(major)=8.57 min;
½aꢁ2D0 = +17.7 (c=1 in CHCl3).
Diisopropyl-3-formyl-3-(4-methoxybenzyl)-4-methylenecyclopen-
tane-1,1-dicarboxylate (2n): Prepared according to the above gen-
eral protocol starting from 1n (80.4 mg, 0.20 mmol) at 408C for
12 days. Yellow oil (49 mg, 61% yield); 1H NMR (300 MHz, CDCl3):
d=9.45 (s, 1H), 7.06 (d, J=8.7 Hz, 2H), 6.79 (d, J=8.7 Hz, 2H), 5.29
(s, 1H), 5.13–4.90 (m, 3H), 3.77 (s, 3H), 3.12 (d, J=14.0 Hz, 1H),
3.00–2.89 (m, 1H), 2.83 (d, J=14.0 Hz, 1H), 2.74–2.63 (m, 2H), 2.42
(d, J=14.3 Hz, 1H), 1.25–1.14 ppm (m, 12H); 13C NMR (75 MHz,
CDCl3): d=199.9, 171.0, 170.7, 158.5, 148.7, 131.2, 128.8, 113.9,
111.1, 69.4, 69.3, 61.8, 58.3, 55.3, 41.6, 41.0, 36.5, 21.6 ppm; HRMS
(ESI): m/z: calcd for C23H30O6Na: 425.1935 [M+Na]+; found:
3-(4-Methoxybenzyl)-4-methylene-1-tosylpyrrolidine-3-carbaldehyde
(6d): Prepared according to the above general protocol starting
from 5d (77.0 mg, 0.20 mmol) at 208C for 13 days. Colorless oil
(63.0 mg, 81% yield); 1H NMR (300 MHz, CDCl3): d=9.37 (s, 1H),
7.65 (d, J=8.2 Hz, 2H), 7.32 (d, J=8.2 Hz, 2H), 6.94 (d, J=8.6 Hz,
2H), 6.75 (d, J=8.6 Hz, 2H), 5.27 (d, J=1.0 Hz, 1H), 5.10 (d, J=
1.0 Hz, 1H), 3.85–3.73 (m, 5H), 3.52 (d, J=10.2 Hz, 1H), 3.25 (d, J=
10.2 Hz, 1H), 3.16 (d, J=14.1 Hz, 1H), 2.79 (d, J=14.1 Hz, 1H),
2.44 ppm (s, 3H); 13C NMR (75 MHz, CDCl3): d=197.7, 158.8, 144.4,
144.2, 132.2, 131.0, 129.8, 128.1, 127.7, 114.1, 111.5, 61.7, 55.3, 52.5,
51.5, 38.8, 21.7 ppm; HRMS (ESI): m/z: calcd for C21H24NO4S:
386.1421 [M+H]+; found: 386.1426; CSP-HPLC (IA, n-hexane/iPrOH
70:30, 1 mLminꢀ1, 215 nm): er=72.5:27.5; tR(minor)=8.58 min, tR-
(major)=10.38 min; ½aꢁ2D0 = +19.2 (c=1 in CHCl3).
425.1941; CSP-HPLC (IC, n-hexane/iPrOH 90:10, 1 mLminꢀ1
,
215 nm): er=88.5:11.5; tR(minor)=10.54 min, tR(major)=13.77 min;
½aꢁ2D0 = +63.0 (c=1 in CHCl3).
2-Methyl-1-methylene-2,3-dihydro-1H-indene-2-carbaldehyde
(4a):[8d] Prepared according to the above general protocol starting
from 3a (34.0 mg, 0.20 mmol) at 208C for 64 h. Colorless oil
(27.2 mg, 80% yield); 1H NMR (300 MHz, C6D6): d=8.94 (s, 1H),
7.05–6.92 (m, 2H), 6.88–6.70 (m, 2H), 5.23 (s, 1H), 4.58 (s, 1H), 3.01
(d, J=16.8 Hz, 1H), 2.13 (d, J=16.8 Hz, 1H), 0.92 ppm (s, 3H); CSP-
HPLC (after NaBH4 mediated reduction in MeOH, OJ, n-hexane/
iPrOH 90:10, 1 mLminꢀ1, 215 nm): er=65:35; tR(minor)=7.24 min,
tR(major)=9.16 min.
3-(2-(Benzyloxy)ethyl)-4-methylene-1-tosylpyrrolidine-3-carbalde-
hyde (6e):[8d] Prepared according to the above general protocol
starting from 5e (79.8 mg, 0.20 mmol) at 208C for 14 days. Color-
1
less solid (68.6 mg, 86% yield); H NMR (300 MHz, CDCl3): d=9.14
(s, 2H), 7.55 (d, J=8.3 Hz, 4H), 7.33–6.93 (m, 17H), 5.05 (s, 2H),
4.90 (s, 2H), 4.22 (s, 4H), 3.78–3.49 (m, 6H), 3.41–3.27 (m, 2H),
3.27–3.13 (m, 2H), 3.05 (d, J=10.1 Hz, 2H), 2.28 (s, 6H), 2.23–2.05
(m, 2H), 1.74–1.54 ppm (m, 2H); CSP-HPLC (IA, n-hexane/iPrOH
90:10, 1 mLminꢀ1, 215 nm): er=75.5:24.5; tR(minor)=19.55 min, tR-
(major)=26.14 min; ½aꢁ2D0 = +20.7 (c=1 in CHCl3).
2-Benzyl-1-methylene-2,3-dihydro-1H-indene-2-carbaldehyde
(4b):[8d] Prepared according to the above general protocol starting
from 3b (50.0 mg, 0.20 mmol) at 208C for 80 h. Colorless oil
3-Phenyl-4-methylene-1-tosylpyrrolidine-3-carbaldehyde
(6 f):[8d]
1
Prepared according to the above general protocol starting from 5 f
(68.2 mg, 0.20 mmol) at 208C for 14 days. Colorless solid (59.0 mg,
(41 mg, 82% yield); H NMR (300 MHz, C6D6): d=9.28 (s, 1H), 7.26–
7.17 (m, 1H), 7.11–6.81 (m, 8H), 5.53 (s, 1H), 4.87 (s, 1H), 3.21 (d,
J=14.0 Hz, 1H), 3.11 (d, J=17.0 Hz, 1H), 2.73 (d, J=14.0 Hz, 1H),
2.70 ppm (d, J=17.0 Hz, 1H); CSP-HPLC (IC, n-hexane/iPrOH 95:5,
1 mLminꢀ1, 215 nm): er=61.5:38.5; tR(minor)=5.66 min, tR(major)=
7.33 min.
1
87% yield); H NMR (300 MHz, CDCl3): d=9.37 (s, 1H), 7.62 (d, J=
8.3 Hz, 2H), 7.34–7.17 (m, 5H), 7.11–7.02 (m, 2H), 5.46 (s, 1H), 5.18–
4.91 (m, 1H), 4.15 (d, J=9.9 Hz, 1H), 4.03–3.73 (m, 2H), 3.21 (d, J=
9.9 Hz, 1H), 2.37 ppm (s, 3H); CSP-HPLC (IA, n-hexane/iPrOH 50:50,
1 mLminꢀ1, 215 nm): er=62.5:37.5; tR(minor)=6.46 min, tR(major)=
12.16 min; ½aꢁ2D0 =ꢀ6.1 (c=1 in CHCl3).
3-Methyl-4-methylene-1-tosylpyrrolidine-3-carbaldehyde
(6a):[8a]
Prepared according to the above general protocol starting from
5a (55.8 mg, 0.20 mmol) at 208C for 1 day. Colorless solid (51 mg,
91% yield); 1H NMR (CDCl3, 300 MHz): d=9.29 (s, 1H), 7,31–7.22
(m, 2H), 7.38–7.34 (m, 2H), 5.21 (t, J=1.8 Hz, 1H), 5.01 (t, J=
2.3 Hz, 1H), 3.88–3.84 (m, 2H), 3.80 (d, J=9.9 Hz, 1H), 3.03 (d, J=
10.0 Hz, 1H), 2.04 (s, 3H), 1.24 ppm (s, 3H); CSP-HPLC (IA, n-
hexane/iPrOH 70:30, 1 mLminꢀ1, 215 nm): er=78:22; tR(minor)=
8.66 min, tR(major)=12.66 min; ½aꢁ2D0 = +30.1 (c=1 in CHCl3).
3-Methyl-4-methylene-1-(4-nitrophenylsulfonyl)pyrrolidine-3-carbal-
dehyde (6g): Prepared according to the above general protocol
starting from 5g (70.4 mg, 0.23 mmol) at 208C for 10 days. Color-
1
less sticky oil (58.0 mg, 82% yield); H NMR (300 MHz, CDCl3): d=
9.19 (s, 1H), 8.48–8.32 (m, 2H), 8.09–7.97 (m, 2H), 5.27 (s, 1H),
5.15–5.06 (m, 1H), 4.02–3.91 (m, 2H), 3.86 (dt, J=13.9, 2.3 Hz, 1H),
3.09 (d, J=10.0 Hz, 1H), 1.26 ppm (s, 3H); 13C NMR (75 MHz,
CDCl3): d=196.8, 150.5, 144.2, 142.1, 129.0, 124.5, 111.6, 57.1, 53.5,
51.9, 18.1 ppm; HRMS (ESI): m/z: calcd for C13H15N2O5S: 311.0696
[M+H]+; found: 311.0701; CSP-HPLC (IA, n-hexane/iPrOH 30:70,
3-Butyl-4-methylene-1-tosylpyrrolidine-3-carbaldehyde (6b):[8d] Pre-
pared according to the above general protocol starting from 5b
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemCatChem 0000, 00, 1 – 11
&
9
&
ÞÞ
These are not the final page numbers!